Process Development Intern - Medical Technology
About the job
- You are currently pursuing a Bachelor's or Master's degree in Mechanical Engineering, Electrical Engineering, Medical Technology, Computer Science, Industrial Engineering, Mechatronics, or a comparable field.
- You have a technical foundation and an interest in manufacturing processes, product development, and innovative technologies.
- You have very good German skills at C1 level and good English skills at B2 level.
- Support the development and optimization of production and manufacturing processes for new medical products.
- Contribute to process-development projects for reusable, navigated instruments as well as innovative computer platforms and software solutions.
- Conduct tests and analyses, support root-cause analysis, and assist in developing technical solutions.
- Take ownership of work packages within interdisciplinary development projects and document the results.
- Work closely with Development, Production, Quality, Purchasing, and external partners.
- Initial knowledge of Process Engineering, Manufacturing Engineering, or technical project work.
About the company
Stryker makes medical devices for hospitals, surgical centers and emergency responders, spanning joint implants, surgical instruments and patient transport equipment. Its Mako platform assists surgeons with joint replacement, while its neurotechnology products support brain and spine procedures and stroke treatment. Clinicians use its equipment during surgery and emergency care, and the company earns money by selling implants, disposable products and capital equipment through direct sales teams and distributors. The business also supplies training and technical support for healthcare providers using its devices. Stryker was founded in 1941 and is headquartered in Portage, Michigan.
Company Size
10,001+
Company Stage
IPO
Headquarters
Kalamazoo, Michigan
Founded
1941
Get referred to Stryker
See people who can refer or advise you
Simplify's Take
What believers are saying
- Demand supports growth: July 2026 Stryker results show organic sales rose 9%, with reported sales reaching $6.6 billion.
- Service extends equipment sales: Stryker's ProCare contracts bundle preventive maintenance, repairs and original manufacturer parts.
- Relocation is available for Worcester technicians: Stryker's live transport service opening also lists 12 paid holidays.
What critics are saying
- Operational failures reach customers: March 2026 cyberattack disrupted Stryker's ordering, manufacturing and shipping.
- Older implants retain legal exposure: Stryker's recall estimates include Rejuvenate, LFIT V40 and legacy Wright hip products.
- Field service demands travel: Stryker's northern Minnesota opening lists 80% travel plus evening or weekend call.
What makes Stryker unique
- Mako combines imaging and physical guidance: Stryker uses CT-based planning and haptic boundaries during hip replacement.
- Discarded devices return to service: Stryker's Sustainability Solutions reprocesses medical equipment for hospitals across the U.S. and Canada.
- Transport extends its technology outside hospitals: Stryker's Power-LOAD supports stretchers while loading and unloading ambulances.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Medical & prescription plans
Supplemental health benefits
Flexible Spending accounts
Employee Assistance Program
Short-term & long-term disability
Tuition reimbursement
401(k) plan
Employee Stock Purchase Plan
Growth & Insights and Company News
6 month growth
0%1 year growth
0%2 year growth
0%Stryker (NYSE:SYK) shares have fallen 20% over the past six months to $277.82, while the S&P 500 gained 12.8%. The medical device maker develops orthopedic, surgical, neurotechnology, and patient care products that reach over 150 million patients a year. Organic revenue, which excludes acquisitions, divestitures, and currency swings, grew an average of 9.2% year-on-year over the past two years. That suggests Stryker can expand without costly acquisitions. Revenue over the past 12 months was $25.84 billion. Its scale gives it leverage with suppliers in a heavily regulated, competitive market. Free cash flow margin rose 6.5 percentage points over five years to 18.2% for the trailing 12 months. After the drop, the stock trades at 17.4× forward earnings.
Stryker announced a $400 million (£300 million) preferred equity investment in CMR Surgical on Monday. The money will support innovation and global expansion of CMR's Versius surgical robotics portfolio. The deal also gives Stryker an exclusive option to acquire 100% of CMR Surgical.
Stryker has launched Mako 4 SmartRobotics in India, introducing the fourth generation of its robotic-arm assisted technology for joint replacement procedures. The system combines patient-specific planning, robotic technology, and haptic guidance for total knee, partial knee, and total hip applications. Mako 4 uses 3D CT-based planning with AccuStop haptic technology to support surgeons in planning and executing procedures according to individual patient anatomy. The platform provides real-time intraoperative guidance for greater precision during joint replacement procedures. The global Mako platform has supported more than 2.5 million procedures across 47 countries. Aman Rishi, Stryker's vice president and general manager for India, said the launch aims to raise the standard of care and expand access for joint replacement patients nationwide.
Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat complex peripheral arterial disease. “This acquisition is a significant milestone in expanding our peripheral vascular portfolio and enhancing our ability to address challenging arterial disease,” said Kevin Lobo, Chair and CEO, Stryker. “By integrating AVS’s innovative CO₂-generated pressure wave technology with Stryker’s scale and resources, we are well-positioned to deliver solutions that support physicians and patient outcomes.” The addition of an IVL platform will strengthen Stryker’s impact in peripheral vascular solutions. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products
Stryker is launching Prophecy Surgical Planning for its Incompass Total Ankle System and introducing Hoffmann LRF smartHEX at the 2026 American Orthopaedic Foot & Ankle Society Annual Meeting in Seattle. Prophecy has supported patient-specific planning for more than 100,000 ankle cases over 14 years. The platform now offers surgeons 3D visualisation and both resect-through and pin-through fixation options within a single connected platform. The Incompass Total Ankle System was designed using insights from Prophecy and Stryker's orthopaedic modelling analytics, incorporating real-world anatomy into the implant design. Hoffmann LRF smartHEX expands Stryker's limb reconstruction portfolio with new rings, struts and frame components. It includes a mobile app and planning software designed to enhance frame versatility and support connected care for complex deformity correction.